13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
![](/mel/img/quote_button.gif) |
SANOFI SA INHABER EO 2 |
920657 |
Xetra |
90,400 |
26.06.24 14:50:19 |
-0,810 |
-0,89% |
90,330 |
90,370 |
91,910 |
91,210 |
![](/mel/img/quote_button.gif) |
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
1.007,500 |
26.06.24 11:44:50 |
+21,500 |
+2,18% |
992,200 |
1.002,500 |
997,200 |
986,000 |